Si le lien ne fonctionne pas, contactez le webmestre pour l'en informer.

 Ressources Externes

General Commentary Relative Bioavailability Risk Assessment: A Systematic Approach to Assessing In Vivo Risk Associated With CM&C-Related Changes Aktham Aburub* , David C. Sperry, Shobha Bhattachar, Evelyn Lobo, Xuan Ding, John P. Rose Lilly Research Labs, Eli Lilly & Company, Indianapolis, Indiana 46285

Journal of Pharmaceutical Sciences,

pdf (??? ko) Téléchargé 94 fois